Potency of Japanese B encephalitis vaccine is tested as follows: On 1st and 4th day, intraperitoneal injection with O.1cc of vaccine respectively, into 30 mice of 3 to 4 week-old, and on 8th day, the test animals as well as 30 mice in control are respectively challenged intraperitoneally with 0.2cc of 10
-1 dilution of mouse brain saline suspension infected with Nakayama strain of Japanese B encephalitis virus. On 22nd day, the test animals must survive over 50% under the conditions of virus infectivity in control being that the LD
50 is over 10
-3, for example 10
-26, and also the mortality in 10
-1 is over 90%. When the LD
50 is under 10
-4, the test must be retested. When the test animals survive over 50%, the vaccine is good.
By using this potency test, authors researched on the antigenic variation of Nakayama strain of Japanese B encephalitis virus.
Mouse brain passaged virus (M: Standard line) was serially passaged through embryonated eggs, and the virus of 2nd, 10th or 20th generation of passage was respectively designated as E
2 E
10, or E
20.
The vaccine prepared from E
2, E
10, or E
20 was respectively designated as E
2Vac, E
10Vac or E
20Vac.
The virus of egg line was serially passaged through mouse brain, and the virus of 2nd., 10th., or 20th, generation of passage was respectively designated as CM
2, CM
10, or CM
20. The vaccine prepared from CM
2 CM
10, or CM
20 was respectively designated as CM
2Vac, CM
10Vac, or CM
20Vac.
The vaccine prepared from M was designated as MVac.
Cross immune tests between E
2Vac, E
10Vac, E
20 Vac, or MVac and E
2, E
10, E
20, or M are carried on.
In the case of challenge with M, the potency of vaccines are as follows: E
2 Vac is highest, E
20 Vac lowest and E
10 Vac intermediace.
That is, the potency decreases parallel with the increase of aggpassage generation. In the case of challenge with E
2, E
10, or E
20, however, the potencies of E
2 Vac, E
10Vac and E
20 Vac are almost the same.
Cross immune tests between CM
2 Vac, CM
10 Vac or MVac and CM
2, CM
10, CM
20 or M are carried on.
The potency of MVac is highest in the case of challenge with M or CM
20, lowest in the case of challenge with CM
2 and intermediate in the case of challenge with CM
10.
CM
20 Vac shows the same tendency as MVac.
The potency of CM
2 Vac is highest in the case of challenge with CM
2, and decreases in due order of CM
10, CM
20 and M.
From the results mentioned above, it is concluded as follows: the antigenicity of mouse brain passaged line of Nakayama strain of Japanese B encephalitis virus varies by serial passage through embryonated eggs and the variation is revresible.
As the antigenic change is caused by host-alternating, it is considerad as “host-controlled variation.”
View full abstract